Financial Gravity Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-34
| Closed | -$3.14K | – | 1017 |
|
|
2021
Q1 | $3.14K | Buy |
+34
| New | +$3.14K | 0.06% | 192 |
|
|
2020
Q2 | – | Sell |
-6
| Closed | -$305 | – | 494 |
|
|
2020
Q1 | $305 | Sell |
6
-8
| -57% | -$407 | ﹤0.01% | 644 |
|
|
2019
Q4 | $104K | Hold |
14
| – | – | 0.07% | 304 |
|
|
2019
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 1054 |
|
|
2019
Q2 | $1K | Sell |
14
-640
| -98% | -$45.7K | ﹤0.01% | 1075 |
|
|
2019
Q1 | $51K | Buy |
+654
| New | +$51K | 0.04% | 312 |
|
|
2018
Q3 | $33K | Buy |
319
+303
| +1,894% | +$31.3K | 0.03% | 414 |
|
|
2018
Q2 | $2K | Buy |
16
+5
| +45% | +$625 | ﹤0.01% | 1004 |
|
|
2018
Q1 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 1185 |
|